Harrell Investment Partners’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
LMFP
ATO
HCM
AAMU
FWCM
Harrell Investment Partners's ABBV Position: Q2 2026 in Review
Harrell Investment Partners reduced its AbbVie (ABBV) stake by 1% in Q2 2026, selling an estimated $68.8K and leaving 31,506 shares worth $7.93M. The position accounts for 1.72% of the portfolio, ranked #13.
Harrell Investment Partners first reported a position in ABBV in Q1 2021 and has held it in 22 quarters since. 1,316 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Harrell Investment Partners held 31,506 shares of AbbVie worth $7.93M as of Q2 2026.
- Harrell Investment Partners sold 320 AbbVie shares in Q2 2026, an estimated $68.8K.
- AbbVie made up 1.72% of Harrell Investment Partners's portfolio in Q2 2026, its #13 holding.
- Harrell Investment Partners first reported a position in AbbVie in Q1 2021 and has held it in 22 quarters since.
- 1,316 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Harrell Investment Partners's 13F filing for Q2 2026, filed 9 Jul 2026.